Researchers from The Children’s Hospital of Philadelphia believe a new first-of-its kind tool will foster shared decision-making among physicians and patients and improve care for children with attention deficit hyperactivity disorder (ADHD).
Experts believe the new, three-part survey will improve communication and teamwork among families and physicians. Similar models of shared-decision making have been used to improve health care results in adults.
The results of the CHOP study are published in the journal Academic Pediatrics.
“Shared decision-making in health care means that doctors and families make decisions together. Doctors contribute their professional knowledge, and families weigh their values and personal experience,” said lead author Alexander Fiks, M.D., M.S.C.E.
“We chose to focus on ADHD for this study, because it is a relatively common diagnosis with two recommended treatment options — prescription medication and behavioral therapy — that require the family to make decisions about what will work best for them.
“Choosing a treatment that doesn’t ‘fit’ can lead to unsuccessful results. We wanted to see if we could create a tool to help guide families and physicians through this process.”
Appropriate treatment of ADHD is a pressing concern as studies suggest the number of physician outpatient visits in which ADHD was diagnosed in children under age 18 was 10.4 million. Psychostimulants such as Ritalin were prescribed in 87 percent of the visits.
The CHOP study involved 237 parents of children aged 6-12 who were diagnosed with ADHD within the past 18 months.
Using a combination of parent interviews, current research, and input from parent advocates and professional experts, researchers developed a standardized three-part questionnaire to help parents define and prioritize their goals for treatment; attitudes toward medication; and comfort with behavioral therapies.
The completed survey serves as a guide to support families and health care providers to reach the most effective and workable treatment for a child’s ADHD.
“It’s important to know whether a parent’s primary goal is to keep a child from getting in trouble at school, improve academic performance, or maintain more peace with family members or peers,” said Fiks.
“We also need to learn about the family’s lifestyle and attitudes toward behavioral therapy and medication. All of these factor into making the best treatment decision for each individual child and family.”
Historically, pediatric care providers make unilateral decisions with minimal input regarding families’ preferences and treatment goals for ADHD.
A new philosophy promulgated by The Institute of Medicine and the American Academy of Pediatrics recommends that healthcare providers use shared decision-making to help families select the best treatment option for ADHD.
A well-designed questionnaire may help both patient-families and providers to feel more satisfied with their child’s ADHD treatment. The researchers say this is a promising model for more widespread use to aid with treatment decisions for children with ADHD and, in the future, could be tailored for use with other medical conditions.
Until the approach is more widely adopted, Fiks and his colleagues recommend parents ask themselves a few questions to help get the most out of their office visit:
“For the pediatrician’s part, it is our responsibility to fully inform parents about their options for treating ADHD and to seek guidance from families about which options will best meet their treatment goals and be manageable for their lifestyle,” said Fiks.
“Research shows that patients adhere much better to the treatment options that they are comfortable with and that are the most practical for them. We need to make sure we’re asking the right questions.”